ACHN Tanks, INNL's Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark

Shares of Innocoll Holdings PLC (INNL) slumped over 44% in extended trading on Thursday as the company's two phase III clinical trials of Cogenzia in patients with moderate to severe diabetic foot infections failed to meet the primary endpoint.

from RTT - Biotech http://ift.tt/2eFVCCs
via IFTTT